No Detail Found!

Unearthing novel PPAR-γ activators: In silico design of eucalyptol analogues for ulcerative colitis

Author(s)
Ozair Khurram Hashmi Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Muhammad Hanzla Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Calvin R. Wei Department of Research and Development, Shing Huei Group,Taipei,Taiwan
Muhammad Aashir Khan Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Muhammad Wassam Bin Wasim Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Muhammad Abdullah Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Syed Hafiz Ahmed Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Muhammad Osama Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistanp;Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Abstract
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with rising prevalence, necessitating novel therapeutics. The peroxisome proliferator-activated receptor gamma (PPAR-?) is a promising target for UC management. This study aimed to identify potent, selective PPAR-? agonists derived from the natural product eucalyptol (1,8-cineole), with reported anti-inflammatory and PPAR-? activating properties but limited clinical utility. A computational workflow encompassing molecular docking of 342 eucalyptol analogues against PPAR-?, pharmacokinetic prediction, and molecular dynamics simulations was employed. Docking revealed five top-scoring hits with higher predicted PPAR-? binding affinities than eucalyptol. AA051 emerged as the most promising candidate, exhibiting the lowest binding free energies (31.16 kcal/mol MMGBSA, -16.53 kcal/mol MMPBSA), favorable ADMET profiles including oral bioavailability, solubility, blood-brain barrier permeability, and conformational stability. AA055 also showed a promising binding profile albeit with initial instability. This study highlights computational approaches in drug discovery, identifying AA051 as a compelling PPAR-? agonist lead for UC therapy, paving the way for experimental validation and optimization of this novel scaffold.
Publication Details
Page(s) 1415-1425
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
molecular docking, natural products, Ulcerative colitis, ADMET, PPAR, agonist, molecular dynamic
References
Acharya R,Chacko S,Bose P,Lapenna A,Pattanayak SP .2019 .Structure based multitargeted molecular docking analysis of selected furanocoumarins against breast cancer. Sci. Rep, 9(1) : 15743.
Agarwal S and Mehrotra R .2016 .An overview of molecular docking. JSM Chem, 4(2) : 1024-1028.
Ahmed B,Ashfaq UA,Qamar MTU,Ahmad M .2014 .Anticancer potential of phytochemicals against breast cancer: Molecular docking and simulation approach. Bangladesh J. Pharmacol., 9(4) : 545-550.
Bertin B,Dubuquoy L,Colombel JF,Desreumaux P .2013 .PPAR-gamma in ulcerative colitis: A novel target for intervention. Curr. Drug Targets, 14(12) : 1501-1507.
Bhura N,Gupta J,Gupta P .2019 .Molecular docking studies of phytochemicals of basil against SIRT2 as an anti-breast cancer. Plant, 19(2) : 2185-2190.
Caioni G,Viscido A,d'Angelo M,Panella G,Castelli V,Merola C,Frieri G,Latella G,Cimini A,Benedetti E .2021 .Inflammatory bowel disease: New insights into the interplay between environmental factors and PPARγ. Int. J. Mol. Sci, 22(3) : 985.
Daina A,Michielin O,Zoete V .2017 .SwissADME: A free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules. Sci. Rep, 7(1) : 42717.
Decara J,Rivera P,López-Gambero AJ,Serrano A,Pavón FJ,Baixeras E,Rodríguez de Fonseca F and Suárez J .2020 .Peroxisome proliferator-activated receptors: Experimental targeting for the treatment of inflammatory bowel diseases. Front, 11 : 730.
Fan C,Basharat Z,Mah K,Wei CR .2024 .Computational approach for drug discovery against Gardnerella vaginalis in quest for safer and effective treatments for bacterial vaginosis. Sci. Rep, 14 : 17437.
Fan C,Memon AAQ,Adhikari P,Osama M,Wei CR .2023 .Revisiting the SARS-COV-2 main protease: A 2023 in Silico Odyssey in search of potential inhibitors. J. Popul. Ther. Clin. Pharmacol, 30(18) : 1032-1049.
Fang J,Wang H,Xue Z,Cheng Y,Zhang X .2021 .PPARγ: The central mucus barrier coordinator in ulcerative colitis. Inflamm. Bowel Dis, 27(5) : 732-741.
Ferretti F,Cannatelli R,Monico MC,Maconi G,Ardizzone S G .2022 .An update on current pharmacotherapeutic options for the treatment of ulcerative colitis. J. Clin. Med, 11(9) : 2302.
Gajendran M,Loganathan P,Jimenez G,Catinella AP,Ng N,Umapathy C,Ziade N,Hashash JG .2019 .A comprehensive review and update on ulcerative colitis. Dis, 65(12) : 100851.
Hoch CC,Petry J,Griesbaum L,Weiser T,Werner K,Ploch M,Verschoor A,Multhoff G,Dezfouli AB,Wollenberg B .2023 .1, 8-cineole (eucalyptol): A versatile phytochemical with therapeutic applications across multiple diseases. Biomed, 167 : 115467.
Izham MNM,Hussin Y,Rahim NFC,Aziz MNM,Yeap SK,Rahman HS,Masarudin MJ,Mohamad NE,Abdullah R,Alitheen NB .2021 .Physicochemical characterization, cytotoxic effect and toxicity evaluation of nanostructured lipid carrier loaded with eucalyptol. BMC Complement. Med, 21 : 1-17.
Kim IS,Silwal P,Jo EK .2023 .Peroxisome proliferator-activated receptor-targeted therapies: Challenges upon infectious diseases. Cells, 12(4) : 650.
Laskowski RA,Moss DS,Thornton JM .1993 .Mainchain bond lengths and bond angles in protein structures. J. Mol. Biol, 231(4) : 1049-1067.
Nguyen TK,Nguyen TNL,Nguyen K,Nguyen HVT,Tran LTT,Ngo TXT,Pham PTV,Tran MH .2022 .Machine learning-based screening of MCF-7 human breast cancer cells and molecular docking analysis of essential oils from Ocimum basilicum against breast cancer. J. Mol. Struct, 1268 : 133627.
Rebhi S,Wei BZ,Lebbal CR,Najjaa S,Sadfi-Zouaoui H,Messaoudi N,A N .2024 .Core proteome mediated subtractive approach for the identification of potential therapeutic drug target against the honeybee pathogen Paenibacillus larvae. , 12 : e17292.
Venkataraman B,Almarzooqi S,Raj V,Bhongade BA,Patil RB,Subramanian VS,Attoub S,Rizvi TA,Adrian TE,Subramanya SB .2023 .Molecular docking identifies 1,8-Cineole (eucalyptol) as a novel PPARγ agonist that alleviates colon inflammation. Int. J. Mol. Sci, 24(7) : 6160.
Wiederstein M and Sippl MJ .2007 .ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res, 35(suppl) : W407-W410.
Wei CR,Osama M,Tahir S M .2025 .A narrative overview of retinoid X receptor inhibitors in chronic disease management. Curr. Drug Res. Rev., 17(3) : 333-342.
0

Citations

0

Downloads

132

Views